CLINICAL AND MOLECULAR GENETIC ANALYSIS OF BEST VITELLIFORM MACULAR DYSTROPHY

Gass, 1997, Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol. 1., 304

Wabbels, 2006, Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy., Graefes Arch Clin Exp Ophthalmol, 244, 1455, 10.1007/s00417-006-0286-6

Weber, 1994, Molecular evidence for non-penetrance in Best’s disease., J Med Genet, 31, 388, 10.1136/jmg.31.5.388

Kramer, 2000, Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration., Eur J Hum Genet, 8, 286, 10.1038/sj.ejhg.5200447

Marmorstein, 2006, Focus on molecules: bestrophin (Best-1)., Exp Eye Res, 85, 423, 10.1016/j.exer.2006.03.021

Petrukhin, 1998, Identification of the gene responsible for Best macular dystrophy., Nat Genet, 19, 241, 10.1038/915

Hartzell, 2008, Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies., Physiol Rev, 88, 639, 10.1152/physrev.00022.2007

Burgess, 2008, Biallelic mutation of BEST1 causes a distinct retinopathy in humans., Am J Hum Genet, 82, 19, 10.1016/j.ajhg.2007.08.004

Yardley, 2004, Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC)., Invest Ophthalmol Vis Sci, 45, 3683, 10.1167/iovs.04-0550

Glybina, 2006, Localization of multifocal electroretinogram abnormalities to the lesion site: findings in a family with Best disease., Arch Ophthalmol, 124, 1593, 10.1001/archopht.124.11.1593

Palmowski, 2003, Detection of retinal dysfunction in vitelliform macular dystrophy using the multifocal ERG (MF-ERG)., Doc Ophthalmol, 106, 145, 10.1023/A:1022550008074

Scholl, 2002, Mapping of retinal function in Best macular dystrophy using multifocal electroretinography., Vision Res, 42, 1053, 10.1016/S0042-6989(02)00034-2

Renner, 2005, Late onset is common in best macular dystrophy associated with VMD2 gene mutations., Ophthalmology, 112, 586, 10.1016/j.ophtha.2004.10.041

Boon, 2007, Clinical and genetic heterogeneity in multifocal vitelliform dystrophy., Arch Ophthalmol, 125, 1100, 10.1001/archopht.125.8.1100

Mohler, 1981, Long-term evaluation of patients with Best’s vitelliform dystrophy., Ophthalmology, 88, 688, 10.1016/S0161-6420(81)34965-3

Costa, 2006, Retinal assessment using optical coherence tomography., Prog Retin Eye Res, 25, 325, 10.1016/j.preteyeres.2006.03.001

Delori, 1995, In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics., Invest Ophthalmol Vis Sci, 36, 718

von Ruckmann, 1997, In vivo fundus autofluorescence in macular dystrophies., Arch Ophthalmol, 115, 609, 10.1001/archopht.1997.01100150611006

Frangieh, 1982, A histopathologic study of Best’s macular dystrophy., Arch Ophthalmol, 100, 1115, 10.1001/archopht.1982.01030040093017

O’Gorman, 1988, Histopathologic findings in Best’s vitelliform macular dystrophy., Arch Ophthalmol, 106, 1261, 10.1001/archopht.1988.01060140421045

Weingeist, 1982, Histopathology of Best’s macular dystrophy., Arch Ophthalmol, 100, 1108, 10.1001/archopht.1982.01030040086016

Holz, 2001, Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration., Invest Ophthalmol Vis Sci, 42, 1051

Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells., Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215

Marquardt, 1998, Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease)., Hum Mol Genet, 7, 1517, 10.1093/hmg/7.9.1517

Bakall, 1999, The mutation spectrum of the bestrophin protein-functional implications., Hum Genet, 104, 383, 10.1007/s004390050972

Lotery, 2000, Allelic variation in the VMD2 gene in best disease and age-related macular degeneration., Invest Ophthalmol Vis Sci, 41, 1291

Mullins, 2005, Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation., Arch Ophthalmol, 123, 1588, 10.1001/archopht.123.11.1588

Kramer, 2003, Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD)., Hum Mutat, 22, 418, 10.1002/humu.9189

Clemett, 1991, Vitelliform dystrophy: long-term observations on New Zealand pedigrees., Aust N Z J Ophthalmol, 19, 221, 10.1111/j.1442-9071.1991.tb00665.x

Spaide, 2008, Autofluorescence from the outer retina and subretinal space: hypothesis and review., Retina, 28, 5, 10.1097/IAE.0b013e318158eca4

Chung, 2001, Visual outcome following subretinal hemorrhage in Best disease., Retina, 21, 575, 10.1097/00006982-200112000-00003

Bakall, 2007, Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2)., Exp Eye Res, 85, 34, 10.1016/j.exer.2007.02.018

Mullins, 2007, Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease., Invest Ophthalmol Vis Sci, 48, 3372, 10.1167/iovs.06-0868

Andrade, 2003, Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease., Am J Ophthalmol, 136, 1179, 10.1016/S0002-9394(03)00711-6

Leu, 2007, Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumab., Graefes Arch Clin Exp Ophthalmol, 245, 1723, 10.1007/s00417-007-0604-7

Yu, 2006, The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function., Invest Ophthalmol Vis Sci, 47, 4956, 10.1167/iovs.06-0524

Hori, 2004, Treatment of cystoid macular edema with oral acetazolamide in a patient with Best vitelliform macular dystrophy., Retina, 24, 481, 10.1097/00006982-200406000-00030

Spaide, 2006, Vitelliform macular dystrophy., Ophthalmology, 113, 1392, 10.1016/j.ophtha.2006.03.023

Querques, 2008, High-definition optical coherence tomography features in vitelliform macular dystrophy., Am J Ophthalmol, 146, 501, 10.1016/j.ajo.2008.05.029

Maruko, 2006, Indocyanine green angiography abnormality of the periphery in vitelliform macular dystrophy., Am J Ophthalmol, 141, 976, 10.1016/j.ajo.2005.12.046

Miller, 1977, Multifocal Best’s vitelliform dystrophy., Arch Ophthalmol, 95, 984, 10.1001/archopht.1977.04450060070004

Boon, 2008, The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene., Prog Retin Eye Res, 27, 213, 10.1016/j.preteyeres.2008.01.002

Renner, 2004, Morphology and functional characteristics in adult vitelliform macular dystrophy., Retina, 24, 929, 10.1097/00006982-200412000-00014

Zhuk, 2006, Peripherin/RDS and VMD2 mutations in macular dystrophies with adult-onset vitelliform lesion., Mol Vis, 12, 811